Bernd Jandeleit
27Patents
9h-index
25Co-inventors
75Inventor score
Filing activity: Feb 18, 1999 → Feb 25, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6043363A | Substituted aminomethylphosphines, compositions and coordination complexes of same, their synthesis and processes using same | Emerging Cross-Sectional Technologies | 82 | Expired |
| US6692914B1 | Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto | Emerging Cross-Sectional Technologies | 56 | Expired |
| US6177528A | Substituted aminomethylphosphines, compositions and coordination complexes of same, their synthesis and processes using same | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6124476A | Catalyst ligands, catalyst compositions, catalyst metal complexes and processes for cross-coupling aromatic boron compounds with aromatic halogens or perfluoroalkylsulfonates | Performing Operations; Transporting | 29 | Expired |
| US7351740B2 | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | Chemistry; Metallurgy | 22 | Active |
| US8168617B2 | Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use | Human Necessities | 18 | Active |
| US6833276B2 | Polymer brushes for immobilizing molecules to a surface and having water-soluble or water-dispersible segments therein and probes bonded thereto | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6472486B2 | Controlled stable free radical emulsion polymerization processes | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7994218B2 | Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use | Human Necessities | 10 | Active |
| US9394237B2 | β-substituted β-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 8 | Active |
| US7592369B2 | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | Chemistry; Metallurgy | 6 | Active |
| US9024055B2 | Acetaminophen conjugates, compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US6559255B2 | Controlled free radical emulsion and water-based polymerizations and seeded methodologies | Chemistry; Metallurgy | 5 | Expired |
| US9783487B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7053076B2 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | Chemistry; Metallurgy | 3 | Expired |
| US9861599B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 3 | Active |
| US7777070B2 | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | Chemistry; Metallurgy | 1 | Active |
| US7727976B2 | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs | Chemistry; Metallurgy | 1 | Active |
| US10034847B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US9682921B2 | β-substituted γ-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US8372881B2 | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | Chemistry; Metallurgy | 0 | Active |
| US9937139B2 | β-substituted γ-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US10246406B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9394236B2 | β-substituted γ-amino acids and analogs as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US12427124B1 | Phenylalanine-based LAT1 inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.